Join the LATISSE® Wishes Challenge

In just two years, LATISSE® (bimatoprost ophthalmic solution) 0.03% and the women across the country who use it have contributed nearly $1.5 million to the Make-A-Wish Foundation®, helping grant the wishes of children with life-threatening medical conditions across the country. LATISSE® is the first and only prescription treatment approved by the U.S. Food and Drug Administration (FDA) to grow lashes longer, fuller and darker for those with inadequate or not enough lashes (eyelash hypotrichosis).

Donate a minimum of $20 to the Make-A-Wish Foundation and Allergan, the makers of LATISSE®, will double your donation and provide you with a LATISSE® free trial certificate to take to your doctor to see if LATISSE® is right for you.* Invite two friends to join you in the LATISSE® Wishes Challenge and you’ll receive a $20 rebate off your next purchase of LATISSE® when you redeem your free trial certificate, limitations apply.

Donate Now by Clicking Here

LATISSE® Indication LATISSE® solution is a prescription treatment for hypotrichosis used to grow eyelashes, making them longer, thicker and darker. Eyelash hypotrichosis is another name for having inadequate or not enough eyelashes. LATISSE® Important Safety Information: If you are using, or have used, prescription products for any eye pressure problems, only use LATISSE® under close doctor care. LATISSE® use may cause increased brown pigmentation of the colored part of the eye which is likely permanent. Eyelid skin darkening may occur which may be reversible. Only apply at the base of the upper eyelashes. DO NOT APPLY to the lower eyelid. Hair growth may occur in other skin areas that LATISSE® solution frequently touches. If you develop or experience any eye problems or have eye surgery, consult your doctor immediately about continued use of LATISSE®. The most common side effects after using LATISSE® solution are itchy eyes and/or eye redness. If discontinued, lashes will gradually return to their previous appearance. *Allergan will double each donation made to the Make-A-Wish Foundation through the LATISSE® Wishes Challenge campaign, with a maximum donation of $250,000 between now and November 30, 2011. When the real time donation ticker hits $375,000, Allergan’s doubled donation has been met and all subsequent consumer donations will continue to benefit the Make-A-Wish Foundation, with no additional donations by Allergan. The total number of LATISSE® free trial certificates is limited to the first 10,000 campaign participants who make a minimum donation of $20 to the Make-A-Wish foundation. Offer limited to one LATISSE® trial certificate per person and U.S. residents only.

August 31, 2011 · by  · in What's New · Tags:

Comments are closed.